Rasagiline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ascend Laboratories, Llc. The primary component is Rasagiline Mesylate.
Product ID | 67877-260_56dcb533-2d6b-430b-9b01-ab4aacd4589a |
NDC | 67877-260 |
Product Type | Human Prescription Drug |
Proprietary Name | Rasagiline |
Generic Name | Rasagiline |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-10-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA201889 |
Labeler Name | Ascend Laboratories, LLC |
Substance Name | RASAGILINE MESYLATE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-10-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA201889 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-30 |
Ingredient | Strength |
---|---|
RASAGILINE MESYLATE | 1 mg/1 |
SPL SET ID: | 5dfeec8f-f4f3-4e06-915e-3244467516a6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0093-3060 | Rasagiline | Rasagiline |
0093-3061 | Rasagiline | Rasagiline |
16714-770 | Rasagiline | Rasagiline |
16714-771 | Rasagiline | Rasagiline |
42291-779 | Rasagiline | Rasagiline |
42291-780 | Rasagiline | Rasagiline |
42571-220 | RASAGILINE | Rasagiline |
42571-221 | RASAGILINE | Rasagiline |
47781-683 | Rasagiline | Rasagiline |
47781-690 | Rasagiline | Rasagiline |
67877-259 | Rasagiline | Rasagiline |
67877-260 | Rasagiline | Rasagiline |